Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma
Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma have?
Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma published?
Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma has 2022 year in the ScholarIQ index.
What is the open-access status of Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma?
Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma?
The DOI for Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma is on the source record.
What is the PMID of Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma?
The PMID for Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma is on the source record.
What is the OpenAlex record for Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma?
The OpenAlex for Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma is on the source record.